02 Jan, 22:45 (IST)

COVID-19 vaccine might contain something, which can cause harm. Tomorrow, people will say vaccine was given to kill/decrease population. You can even become impotent, anything can happen: Mirzapur SP MLC Ashutosh Sinha on SP Chief Akhilesh Yadav saying he won't get vaccinated.

02 Jan, 22:23 (IST)

Bharat Biotech has announced successful recruitment of 23,000 volunteers, and continued progress towards achieving the goal of 26,000 participants for Phase-3 clinical trial of COVAXIN across multiple sites in India: Statement.

02 Jan, 21:39 (IST)

A mock drill on COVID-19 vaccine administration was held in all states and Union Territories at 286 session sites spread across 125 districts. Around 1,14,100 vaccinators were trained. More than 75 lakhs beneficiaries have been registered on Co-WIN software till date: Government of India.

02 Jan, 20:40 (IST)

The Drug Controller General of India (DCGI) will brief the media at 11 am tomorrow on COVID-19 vaccines.

02 Jan, 20:31 (IST)

Night curfew from 8 pm to 6 am will be in force within the urban limits of the district head quarter towns of 13 districts — Kota, Jaipur, Jodhpur, Bikaner, Udaipur, Ajmer, Alwar, Bhilwara, Nagore, Pali, Tonk, Sikar and Ganganagar: Rajasthan Government.

02 Jan, 20:06 (IST)

Mumbai reports 592 new COVID-19 cases, 695 recoveries/discharges and 7 deaths today.Total cases rise to 2,94,659 including 2,74,767 recoveries/discharges and 11,132 deaths.Active cases stand at 7,892.

02 Jan, 19:24 (IST)

All shops and commercial establishments in Karnataka employing ten or more persons are permitted to remain open on 24X7 basis on all days of the year for a period of 3 years from today: State Government.

02 Jan, 19:06 (IST)

CDSCO panel recommends granting approval to Bharat Biotech's indigenous COVID vaccine Covaxin.

02 Jan, 19:00 (IST)

Tamil Nadu reported 910 new COVID-19 cases, 1,007 discharges, and 11 deaths in the last 24 hours, the state Health Department said. Total cases: 8,19,845. Total discharges: 7,99,427. Death toll: 12,146. Active cases: 8,272.

02 Jan, 18:32 (IST)

India successfully cultures the new viral strain on the horizon (UK-variant of SARS-CoV-2): Indian Council of Medical Research (ICMR).

Load More

New Delhi, January 2: India will conduct a dry run for the coronavirus (COVID-19) vaccination in all states and union territories today. The dry run of the COVID-19 vaccination will be carried out in all state capitals in at least three session sites. According to India's Ministry of Health and Family Welfare, "the objective of the dry run for COVID-19 vaccine introduction is to assess operational feasibility in the use of Co-WIN application in field environment, to test the linkages between planning and implementation and to identify the challenges and guide way forward prior to actual implementation." Catch live breaking news and latest updates on India, politics, sports, entertainment, business, technology and world affairs here. India Reports 20,035 New Coronavirus Cases in Past 24 Hours, COVID-19 Count Surges to 1,02,86,710.

The India Meteorological Department has predicted rainfall in parts of Uttar Pradesh and Haryana today. According to the IMD, light to moderate intensity rain would occur over and adjoining areas of Mahendargarh,   Kosli, Hansi, Tosham,  Rohtak, Jind, Safodon, Panipat, Gohana, Karnal, Shamli, Kaithal, Deoband, Saharanpur, Narwana, Bagpat, Narnaul and Deeg.

The Subject Expert Committee (SEC) of the Central Drug Standard Control Organisation (CDSCO) on Friday recommended Covishield, a potential vaccine against coronavirus (COVID-19), for emergency use approval in India. Pune-based Serum Institute of India has partnered with Covishield developer Oxford-AstraZeneca for conducting clinical trials and manufacturing of the vaccine.

The SEC also held that the data provided by Bharat Biotech for its coronavirus vaccine Covaxin is not sufficient for grant of emergency use approval and has asked for more information. The committee had convened a meeting to take a call on the emergency use authorisation sought by the Serum Institute, Bharat Biotech and America's Pfizer for their coronavirus vaccines candidates.